BRIEF-ViroPharma jumps in premarket after FDA lifts hold on Cinryze testing

NEW YORK, Sept 21 Fri Sep 21, 2012 8:12am EDT

NEW YORK, Sept 21 (Reuters) - ViroPharma Inc : * Jumps 6.5 percent to $30 in premarket after FDA lifts hold on Cinryze testing

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.